| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| U.S. Stem Cell, Inc. | Director | Common Stock | 38,005,331 | $152,021 | $0.004000 | 25 Apr 2022 | Held by NorthStar Biotech Group, LLC of which Gregory Knutson is Managing Director |
| U.S. Stem Cell, Inc. | Director | Common Stock | 29,175,000 | $116,700 | $0.004000 | 25 Apr 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| USRM | U.S. Stem Cell, Inc. | 25 Apr 2022 | 1 | +$10,000 | 4 | Director | 29 Apr 2022, 16:28 |
| USRM | U.S. Stem Cell, Inc. | 18 Mar 2022 | 3 | +$1,250,000,200,000 | 4 | Director | 25 Mar 2022, 16:02 |
| USRM | U.S. Stem Cell, Inc. | 24 Feb 2022 | 2 | +$1,250,000,000,000 | 4 | Director | 04 Mar 2022, 15:01 |
| USRM | U.S. Stem Cell, Inc. | 01 Apr 2020 | 4 | +$375,939,826,970 | 4 | Director | 23 Jul 2021, 16:02 |